CAS RN: 1092582-89-2
8H-Indeno[1,2-d]oxazole, 2,2′-(1-ethylpropylidene)bis[3a,8a-dihydro-, (3aR,3’aR,8aS,8’aS)-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250617
100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1092582-89-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
>97%
0
Out of Stock
Shanghai
Inquiry
1092582-89-2 / (3aS,8bR)-2-[3-[(3aS,8bR)-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazol-2-yl]pentan-3-yl]-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazole
Standard CAS: 1092582-89-2
Multi CAS: Yes
Basic Information
copy
CAS
1092582-89-2 copy
Multi CAS
Yes copy
Molecular Formula
C25H26N2O2 copy
Molecular Weight
386.500000 copy
Exact Mass
386.199428 copy
SMILES
CCC(CC)(C1=N[C@H]2[C@@H](O1)CC3=CC=CC=C23)C4=N[C@H]5[C@@H](O4)CC6=CC=CC=C56 copy
InChI
InChI=1S/C25H26N2O2/c1-3-25(4-2,23-26-21-17-11-7-5-9-15(17)13-19(21)28-23)24-27-22-18-12-8-6-10-16(18)14-20(22)29-24/h5-12,19-22H,3-4,13-14H2,1-2H3/t19-,20-,21+,22+/m0/s1 copy
InChIKey
OQLUHXFWGUDHNB-FNAHDJPLSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
29 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.44 copy
Rotatable bonds
4 copy
H-bond acceptors
4 copy
Molar refractivity
113.41 copy
TPSA
43.18 copy
LogP / Solubility
WLOGP
4.98 copy
MLOGP
4.41 copy
XLogP3
4.7 copy
Consensus LogP
4.7 copy
Log S (ESOL)
-5.42 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.33 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.79 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.54 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
6 copy